10x Genomics announced three clinical‑focused collaborations and plans to open a CLIA‑certified lab in early 2027 to accelerate adoption of single‑cell and spatial assays in oncology and immunology. Partnerships include Dana‑Farber, the Cancer Research Institute and Brigham and Women’s Hospital to build large clinical datasets for biomarker discovery and AI benchmarking. Financials show consumables remain the growth engine even as instrument placements fluctuate: 10x reported preliminary revenue driven by consumables and services while instrument sales declined year over year. The strategy signals a shift toward delivering clinical workflows, reference datasets and service offerings that support biopharma and diagnostic translation.